General care population | General care population | Intensive care population | P value between populations (GTT/TT) | ||||
HMPS methodology | GTT/TT methodology | ||||||
N of samples | Pooled estimates (95% PI) | N of samples | Pooled estimates (95% PI) | N of samples | Pooled estimates (95% PI) | ||
Primary outcome | |||||||
Percentage of admissions with ≥1 AEs | 9 | 3.9 (0.3–33.7) | 13 | 17.7 (3.8–53.8) | 10 | 47.3 (6.9–91.6) | 0.0003 |
Secondary outcomes | |||||||
AEs per 100 admissions | – | – | 13 | 24.8 (4.2–145.2) | 11 | 103.6 (15.3–699.7) | < 0.0001 |
AEs per 1000 patient days | – | – | 12 | 48.3 (5.9–393.1) | 10 | 126.2 (6.4–2495.1) | 0.0418 |
Percentage of preventable AEs | 5 | 53.2 (10.4–91.8) | 4 | 58.6 (7.4–96.2) | 7 | 67.4 (4.5–98.9) | 0.5355 |
Percentage of admissions with preventable AEs | 4 | 2.3 (0.0–59.3) | 3 | 7.3 (0.0–100.0) | 5 | 25.0 (2.5–81.3) | 0.0467 |
AEs, adverse events; GTT, Global Trigger Tool; HMPS, Harvard Medical Practice Study; PI, prediction interval; TT, Trigger Tool.